191 related articles for article (PubMed ID: 15279697)
1. Pathogenesis of respiratory syncytial virus infection.
Tripp RA
Viral Immunol; 2004; 17(2):165-81. PubMed ID: 15279697
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiologic features of respiratory syncytial virus.
Hall CB; Simőes EA; Anderson LJ
Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
[TBL] [Abstract][Full Text] [Related]
3. Innate immune responses in respiratory syncytial virus infections.
Krishnan S; Halonen M; Welliver RC
Viral Immunol; 2004; 17(2):220-33. PubMed ID: 15279701
[TBL] [Abstract][Full Text] [Related]
4. The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma.
Zeng R; Li C; Li N; Wei L; Cui Y
Cytokine; 2011 Jan; 53(1):1-7. PubMed ID: 21035355
[TBL] [Abstract][Full Text] [Related]
5. Impaired immune response in severe human lower tract respiratory infection by respiratory syncytial virus.
Larrañaga CL; Ampuero SL; Luchsinger VF; Carrión FA; Aguilar NV; Morales PR; Palomino MA; Tapia LF; Avendaño LF
Pediatr Infect Dis J; 2009 Oct; 28(10):867-73. PubMed ID: 19738511
[TBL] [Abstract][Full Text] [Related]
6. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection.
de Waal L; Koopman LP; van Benten IJ; Brandenburg AH; Mulder PG; de Swart RL; Fokkens WJ; Neijens HJ; Osterhaus AD
J Med Virol; 2003 Jun; 70(2):309-18. PubMed ID: 12696123
[TBL] [Abstract][Full Text] [Related]
7. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
Groothuis JR; Hoopes JM; Hemming VG
Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
[TBL] [Abstract][Full Text] [Related]
8. Advances in and the potential of vaccines for respiratory syncytial virus.
Jorquera PA; Oakley KE; Tripp RA
Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
[TBL] [Abstract][Full Text] [Related]
9. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
Shafique M; Wilschut J; de Haan A
Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
[TBL] [Abstract][Full Text] [Related]
10. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
[TBL] [Abstract][Full Text] [Related]
11. Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.
Descamps D; Peres de Oliveira A; Gonnin L; Madrières S; Fix J; Drajac C; Marquant Q; Bouguyon E; Pietralunga V; Iha H; Morais Ventura A; Tangy F; Vidalain PO; Eléouët JF; Galloux M
J Virol; 2021 Oct; 95(22):e0091221. PubMed ID: 34431698
[TBL] [Abstract][Full Text] [Related]
12. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
Munoz FM
Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus infection in adults.
Falsey AR
Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
[TBL] [Abstract][Full Text] [Related]
15. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
16. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response.
Harris J; Werling D
Cell Microbiol; 2003 Oct; 5(10):671-80. PubMed ID: 12969373
[TBL] [Abstract][Full Text] [Related]
17. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with respiratory syncytial virus vaccines.
Piedra PA
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus and pulmonary surfactant.
Griese M
Viral Immunol; 2002; 15(2):357-63. PubMed ID: 12081017
[TBL] [Abstract][Full Text] [Related]
20. Host response to respiratory syncytial virus infection.
Arruvito L; Raiden S; Geffner J
Curr Opin Infect Dis; 2015 Jun; 28(3):259-66. PubMed ID: 25887611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
